- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03563690
Different Kinds of Acupuncture Treatment for Knee Osteoarthritis
June 6, 2023 updated by: Jianqiao Fang, Zhejiang Chinese Medical University
Different Kinds of Acupuncture Treatment for Knee Osteoarthritis:a Multicentre Randomised Controlled Trial
Knee osteoarthritis (KOA) a chronic disease with symptoms of persistent pain or rest pain , joint stiffness, numbness, limitation of activity and even disability, with significant associated costs and effects on individuals' life quality.
Acupuncture as an approach for the management of chronic pain, is receiving increasing recognition from both the public and professionals.
The aim of this study is to indicate the effects of three commonly used acupuncture treatments for KOA.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
360 subjects with KOA recruited from six centers will be randomized to six groups ,and receive four-week acupuncture, Electro-acupuncture, Moxibustion ,Warm-needling ,sham-needle, celebrex treatment.
The primary outcomes are Visual Analogue Scale (VAS) and WOMAC function score.The Secondary outcomes are WOMAC pain score, WOMAC stiffness score,the Physical Activity Scale of the Elderly (PASE),knee joint swelling measurement and WHO-BREF life quality scale.The follow-up period is six months.
This study will be a rigorous,randomized, sham and drug controlled trial focusing on using different kinds of acupuncture treatment for treating KOA.
Study Type
Interventional
Enrollment (Actual)
360
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China
- The third affiliated hospital of Zhejiang CMU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Meet the Clinical Classification Criteria for Osteoarthritis of the Knee, diagnosed by specialist.
- Aged 40-75 years old;
- History of chronic knee pain for more than 3 months, and complain of knee pain on most days of the past month;
- Kellgren and Lawrence Grades 1-3;
- With related knee pain in one or both knees rated > 4 cm on a 10 cm Visual Analog Scale(VAS) (VAS:0 to 10)
- Who volunteer to participate and sign the consent form .
Exclusion Criteria:
- Knee osteoarthritis patients with gout, infection, tumor, autoimmune diseases, trauma or other causes of knee pain or knee deformities;
- Patients who have local skin damage, poor skin conditions or coagulant dysfunction and patients who are not suitable for acupuncture;
- Patients who are accompanied with serious medical problems or mental disorders, cognitive dysfunction,disorders of shallow sensation or who cannot cooperate with the treatment;
- Patients who have received acupuncture or needle knife in the past month;
- Other patients who are not suitable for acupuncture treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Acupuncture group
When recruited from six centers,the participant will be randomized to six groups .In acupuncture group participant will receive four-week acupuncture treatment(three times a week )continuously for 4 weeks,12 treatments in total.
The follow-up period is six months.
|
|
|
Experimental: Electro-acupuncture group
When recruited from six centers,the participant will be randomized to six groups.
In this group participant receive four-week electro-acupuncture treatment(three times a week )continuously for 4 weeks,12 treatments in total.
The follow-up period is six months.
|
|
|
Experimental: Moxibustion group
When recruited from six centers,the participant will be randomized to six groups.
In this group participant receive four-week moxibustion treatment (three times a week )continuously for 4 weeks,12 treatments in total.
The follow-up period is six months.
|
|
|
Experimental: Warm-needling group
When recruited from six centers,the participant will be randomized to six groups.
In this group participant receive four-week warm-needling treatment (three times a week )continuously for 4 weeks,12 treatments in total.
The follow-up period is six months.
|
|
|
Sham Comparator: Sham-needle group
When recruited from six centers,the participant will be randomized to six groups.In this group participant receive four-week sham acupuncture treatment (three times a week )continuously for 4 weeks,12 treatments in total.
The follow-up period is six months.
|
|
|
Active Comparator: Celebrex group
When recruited from six centers,the participant will be randomized to six groups .
In this group participant will receive Celebrex (Celebrex, Capsules, Pfizer Pharmaceuticals Ltd)treatment, which will be applied 1 time daily(one time oral 0.2g) for 4 weeks.
The follow-up period is six months.
|
Drug: Celebrex (Celebrex, Capsules, Pfizer Pharmaceuticals Ltd), which will be applied 1 time daily( taken 0.2g one time orally ) Time of treatment :4 weeks Other Name: celecoxib
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Score change
Time Frame: baseline,2 weeks, 4 weeks ,3 months,6months
|
Intensity of pain range (lately 3 days' average): 0 =no pain to 10 =worst possible pain.
Higher score indicating severe pain.
|
baseline,2 weeks, 4 weeks ,3 months,6months
|
|
WOMAC function change
Time Frame: baseline,2 weeks,4 weeks ,3 months,6months
|
The WOMAC function subscale referred to the participant's ability to move around and perform usual activities of daily living.
The WOMAC function subscale was comprised of 17 questions regarding the degree of difficulty experienced due to OA in the study knee.
The WOMAC function subscale score for each question ranged from 0 (minimum) to 4 (maximum), higher scores signified worse physical function.
An overall score range of 0 (minimum) to 68 (maximum), with higher scores indicating worse physical function.
|
baseline,2 weeks,4 weeks ,3 months,6months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
WOMAC pain change
Time Frame: baseline,2 weeks,4weeks ,3 months,6months
|
The WOMAC pain subscale referred to the patient's pain.
It was comprised of 5 items, with each item scored from 0 (minimum) to 4 (maximum), where 4 indicated worst pain condition.
An overall score range of 0 (minimum) to 20 (maximum), with higher scores indicating worse physical function.
|
baseline,2 weeks,4weeks ,3 months,6months
|
|
WOMAC stiffness change
Time Frame: baseline,2 weeks,4 weeks ,3 months,6months
|
The WOMAC stiffness subscale was comprised of 2 questions regarding the degree of stiffness experienced in the study knee.
The WOMAC stiffness subscale score for each question ranged from 0 (minimum) to 4 (maximum), higher scores signified worse stiffness.
An overall score range of 0 (minimum) to 8 (maximum), with higher scores indicating more stiffness.
|
baseline,2 weeks,4 weeks ,3 months,6months
|
|
PASE change
Time Frame: baseline,2 weeks,4 weeks ,3 months,6months
|
Physical Activity Scale for the Elderly was comprised of 36 questions regarding physical activity of elderly's house hold,leisure,work performance with different score weight.The higher scores indicating better physical activity.
|
baseline,2 weeks,4 weeks ,3 months,6months
|
|
Quality of life change
Time Frame: baseline,2 weeks,4 weeks ,3 months,6months
|
WHO-BREF 36-Item Form assessing quality of life was comprised of 26 items which measured the following broad domains: physical health, psychological health, social relationships, and environment.With higher scores indicating better quality of life.
|
baseline,2 weeks,4 weeks ,3 months,6months
|
|
Knee swelling measurement change
Time Frame: baseline,2 weeks, 4 weeks ,3 months,6months
|
0-3 score indicating swelling and average Knee circumference of three times.
|
baseline,2 weeks, 4 weeks ,3 months,6months
|
|
Expectancy questionnaires
Time Frame: baseline
|
Expectancy questionnaires were comprised of two brief items assessing the expectancy of the patients about acupuncture(or/and)moxibustion.
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jianqiao Fang, Ph.D,M.D, Zhejiang CMU
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008 Feb;16(2):137-62. doi: 10.1016/j.joca.2007.12.013.
- Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646-56. Epub 2003 Nov 14.
- Gelber AC. Conventional medical therapy for osteoarthritis: current state of the evidence. Curr Opin Rheumatol. 2015 May;27(3):312-7. doi: 10.1097/BOR.0000000000000164.
- Holla JF, van der Leeden M, Knol DL, Roorda LD, Hilberdink WK, Lems WF, Steultjens MP, Dekker J. Predictors and outcome of pain-related avoidance of activities in persons with early symptomatic knee osteoarthritis: a five-year followup study. Arthritis Care Res (Hoboken). 2015 Jan;67(1):48-57. doi: 10.1002/acr.22381.
- WHO Scientific Group on the Burden of Musculoskeletal Conditions at the Start of the New Millennium. The burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser. 2003;919:i-x, 1-218, back cover.
- Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China. Rheumatol Int. 2009 Mar;29(5):481-90. doi: 10.1007/s00296-008-0809-z. Epub 2008 Dec 6.
- Zhang Q, Fang J, Chen L, Wu J, Ni J, Liu F, Sun J. Different kinds of acupuncture treatments for knee osteoarthritis: a multicentre, randomized controlled trial. Trials. 2020 Mar 14;21(1):264. doi: 10.1186/s13063-019-4034-8.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 3, 2018
Primary Completion (Actual)
October 28, 2021
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
May 17, 2018
First Submitted That Met QC Criteria
June 19, 2018
First Posted (Actual)
June 20, 2018
Study Record Updates
Last Update Posted (Actual)
June 8, 2023
Last Update Submitted That Met QC Criteria
June 6, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Arthritis
- Osteoarthritis
- Osteoarthritis, Knee
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Cyclooxygenase 2 Inhibitors
- Celecoxib
Other Study ID Numbers
- 2018ZY008-KOA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Dr. David WassersteinSunnybrook Research InstituteRecruitingKnee Osteoarthritis (Knee OA) | Knee Osteoarthritis (OA)Canada
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
Lucas R. Cusumano, MDNot yet recruitingKnee Osteoarthritis | Knee Discomfort | Knee Pain Chronic | Knee Swelling PainUnited States
-
VA Office of Research and DevelopmentNot yet recruitingKnee Osteoarthritis (Knee OA)United States
-
The Hong Kong Polytechnic UniversityChinese University of Hong Kong; Zhujiang HospitalNot yet recruitingKnee Osteoarthritis (Knee OA)
-
University of MiamiNot yet recruiting
-
Kutahya Health Sciences UniversityActive, not recruitingKnee Osteoarthritis | Knee DiseaseTurkey (Türkiye)
Clinical Trials on treatment1
-
Clinical Nutrition Research Center, Illinois Institute...Verdure SciencesCompleted